SARS-CoV-2 Infection of Salivary Glands Compromises Oral Antifungal Innate Immunity and Predisposes to Oral Candidiasis

Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunist...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Alfaifi, Areej A, Wang, Tristan W, Perez, Paola, Sultan, Ahmed S, Meiller, Timothy F, Rock, Peter, Kleiner, David E, Chertow, Daniel S, Hewitt, Stephen M, Gasmi, Billel, Stein, Sydney, Ramelli, Sabrina, Martin, Daniel, Warner, Blake M, Jabra-Rizk, Mary Ann
Format Journal Article Paper
LanguageEnglish
Published United States Cold Spring Harbor Laboratory 11.06.2024
Edition1.2
Subjects
Online AccessGet full text
ISSN2692-8205
2692-8205
DOI10.1101/2024.05.13.593942

Cover

Loading…
Abstract Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen . Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of . Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of was demonstrated using an assay where was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.
AbstractList Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis. Saliva contains antimicrobial peptides part of host innate immunity crucial for protection against colonizing microbial species. Most notable is the antifungal peptide histatin-5 produced in salivary glands cells. SARS-CoV-2 was shown to replicate in salivary gland cells causing tissue inflammation. In this study, we showed decreased expression of histatin genes in salivary glands from COVID-19 autopsies, and co-localization studies of SARS-CoV-2 spike and histatin revealed absence or minimal presence of histatin in acinar cells with replicating virus. To investigate the clinical implications of these findings, we conducted studies using saliva samples from subjects with mild to severe COVID-19, matched with healthy controls. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects with enhanced prevalence of C. albicans. Prospective analysis indicated the decrease in histatin-5 is reversible in mild-moderate disease, and salivary cytokine profiling demonstrated activation of the Th17 inflammatory pathway. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in saliva with low histatin-5, but not with high histatin-5. Collectively, the findings provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity and predisposition to oral candidiasis.
Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen . Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of . Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of was demonstrated using an assay where was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.
Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.
Author Rock, Peter
Martin, Daniel
Perez, Paola
Sultan, Ahmed S
Wang, Tristan W
Stein, Sydney
Jabra-Rizk, Mary Ann
Chertow, Daniel S
Hewitt, Stephen M
Meiller, Timothy F
Warner, Blake M
Gasmi, Billel
Kleiner, David E
Alfaifi, Areej A
Ramelli, Sabrina
Author_xml – sequence: 1
  givenname: Areej A
  surname: Alfaifi
  fullname: Alfaifi, Areej A
  organization: King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia
– sequence: 2
  givenname: Tristan W
  surname: Wang
  fullname: Wang, Tristan W
  organization: Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland Baltimore, Maryland, United States of America
– sequence: 3
  givenname: Paola
  surname: Perez
  fullname: Perez, Paola
  organization: Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America
– sequence: 4
  givenname: Ahmed S
  surname: Sultan
  fullname: Sultan, Ahmed S
  organization: University of Maryland Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States of America
– sequence: 5
  givenname: Timothy F
  surname: Meiller
  fullname: Meiller, Timothy F
  organization: University of Maryland Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States of America
– sequence: 6
  givenname: Peter
  surname: Rock
  fullname: Rock, Peter
  organization: Department of Anesthesia, School of Medicine, University of Maryland Baltimore, Maryland, United States of America
– sequence: 7
  givenname: David E
  surname: Kleiner
  fullname: Kleiner, David E
  organization: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
– sequence: 8
  givenname: Daniel S
  surname: Chertow
  fullname: Chertow, Daniel S
  organization: Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States of America, USA
– sequence: 9
  givenname: Stephen M
  surname: Hewitt
  fullname: Hewitt, Stephen M
  organization: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
– sequence: 10
  givenname: Billel
  surname: Gasmi
  fullname: Gasmi, Billel
  organization: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
– sequence: 11
  givenname: Sydney
  surname: Stein
  fullname: Stein, Sydney
  organization: Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
– sequence: 12
  givenname: Sabrina
  surname: Ramelli
  fullname: Ramelli, Sabrina
  organization: Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
– sequence: 13
  givenname: Daniel
  surname: Martin
  fullname: Martin, Daniel
  organization: Genomics and Computational Biology Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America
– sequence: 14
  givenname: Blake M
  surname: Warner
  fullname: Warner, Blake M
  organization: Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America
– sequence: 15
  givenname: Mary Ann
  orcidid: 0000-0002-4425-3873
  surname: Jabra-Rizk
  fullname: Jabra-Rizk, Mary Ann
  organization: Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38798323$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtOwzAURC1UxKP0A9ggL9mkXNuxkyyrCEolpCIKbCM7dpBRYpc4KfTvSdXyWN2R7sxIZ87RyHlnELokMCUEyA0FGk-BTwmb8oxlMT1CZ1RkNEop8NE_fYomIbwDAM0EYUl8gk5ZmmQpo-wMfa5mT6so968RxQtXmbKz3mFf4ZWs7Ua2WzyvpdMB575Zt76xwQS8bGWNZ66zVe_eBrlwTnYGL5qmd7bb4iGAH1ujbVj7nb_z-0g-PKy2MthwgY4rWQczOdwxerm7fc7vo4flfJHPHiJFGKWRZkIkisSKCwVlynildSIyluqs5EzplIAmNKkk1VqWqQaiTKnKRIEQMXDGxuh636usb7_spli3thmwit18BfCCsGI_35914PzoTeiKgbY09cBvfB8KBgISDjRJB-vVwdqrxujf0p9d2TePRHsi
ContentType Journal Article
Paper
Copyright 2024, Posted by Cold Spring Harbor Laboratory
Copyright_xml – notice: 2024, Posted by Cold Spring Harbor Laboratory
DBID NPM
7X8
FX.
DOI 10.1101/2024.05.13.593942
DatabaseName PubMed
MEDLINE - Academic
bioRxiv
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: FX.
  name: bioRxiv
  url: https://www.biorxiv.org/
  sourceTypes: Open Access Repository
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2692-8205
Edition 1.2
ExternalDocumentID 2024.05.13.593942v2
38798323
Genre Journal Article
Preprint
GrantInformation_xml – fundername: NIDCR NIH HHS
  grantid: R21 DE031888
– fundername: NIDCD NIH HHS
  grantid: R01 DC000086
– fundername: Intramural NIH HHS
  grantid: ZIC DC000086
– fundername: Intramural NIH HHS
  grantid: Z01 DE000704
– fundername: Intramural NIH HHS
  grantid: ZIA CL090070
GroupedDBID 8FE
8FH
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
CCPQU
HCIFZ
LK8
M7P
NPM
NQS
PHGZT
PIMPY
PMFND
PROAC
RHI
7X8
PHGZM
PQGLB
PUEGO
FX.
ID FETCH-LOGICAL-b1322-d3667b14b56b0c835fdd76938d9c53bd810d127fa2ddac8d01becbc7b06640533
IEDL.DBID FX.
ISSN 2692-8205
IngestDate Tue Jan 07 18:56:18 EST 2025
Fri Sep 05 14:57:55 EDT 2025
Sat May 31 02:13:28 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
License This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at http://creativecommons.org/licenses/by-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b1322-d3667b14b56b0c835fdd76938d9c53bd810d127fa2ddac8d01becbc7b06640533
Notes ObjectType-Working Paper/Pre-Print-3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interest Statement: The authors have declared no competing interest.
ORCID 0000-0002-4425-3873
OpenAccessLink https://www.biorxiv.org/content/10.1101/2024.05.13.593942
PMID 38798323
PQID 3060750278
PQPubID 23479
PageCount 35
ParticipantIDs biorxiv_primary_2024_05_13_593942
proquest_miscellaneous_3060750278
pubmed_primary_38798323
PublicationCentury 2000
PublicationDate 2024-Jun-11
20240611
PublicationDateYYYYMMDD 2024-06-11
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-Jun-11
  day: 11
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle bioRxiv
PublicationTitleAlternate bioRxiv
PublicationYear 2024
Publisher Cold Spring Harbor Laboratory
Publisher_xml – name: Cold Spring Harbor Laboratory
References Shen, Voigt, Goranova, Abed, Kleiner, Maldonado (2024.05.13.593942v2.29) 2023; 8
Vila, Sultan, Montelongo-Jauregui, Jabra-Rizk (2024.05.13.593942v2.20) 2020; 6
Salehi, Ahmadikia, Mahmoudi, Kalantari, Jamalimoghadamsiahkali, Izadi (2024.05.13.593942v2.3) 2020; 63
Situ, Bobek (2024.05.13.593942v2.18) 2000; 44
Pascolo, Zupin, Melato, Tricarico, Crovella (2024.05.13.593942v2.25) 2020; 99
Pisano, Romano, Di Palo, Baroni, Serpico, Contaldo (2024.05.13.593942v2.30) 2023; 11
Khan, Fidel Jr, Al Thunayyan, Meiller, Jabra-Rizk (2024.05.13.593942v2.31) 2013; 4
Amorim Dos Santos, Normando, Carvalho da Silva, De Paula, Cembranel, Santos-Silva (2024.05.13.593942v2.1) 2020; 97
Fidel (2024.05.13.593942v2.22) 2006; 19
Brandini, Takamiya, Thakkar, Schaller, Rahat, Naqvi (2024.05.13.593942v2.6) 2021; 31
Sabatini, Azen (2024.05.13.593942v2.13) 1994; 4
Gaffen, Moutsopoulos (2024.05.13.593942v2.32) 2020; 5
Corchuelo, Ulloa (2024.05.13.593942v2.26) 2020; 100
Jabra-Rizk, Kong, Tsui, Nguyen, Clancy, Fidel (2024.05.13.593942v2.19) 2016; 84
Sultan, Kong, Rizk, Jabra-Rizk (2024.05.13.593942v2.9) 2018; 14
Alfaifi, Sultan, Montelongo-Jauregui, Meiller, Jabra-Rizk (2024.05.13.593942v2.38) 2022; 12
Nikawa, Jin, Fukushima, Makihira, Hamada (2024.05.13.593942v2.17) 2001; 16
Salehi, Ahmadikia, Badali, Khodavaisy (2024.05.13.593942v2.2) 2020; 185
Song, Li, Huang, Chen, Li, Liu (2024.05.13.593942v2.23) 2020; 92
Pavlova, Sharafutdinov (2024.05.13.593942v2.33) 2020; 8
Kong, Tsui, Boyce, Ibrahim, Hoag, Karlsson (2024.05.13.593942v2.34) 2015; 60
Riad, Gad, Ockova, Klugar (2024.05.13.593942v2.4) 2020; 15
Edgerton, Koshlukova, Lo, Chrzan, Straubinger, Raj (2024.05.13.593942v2.15) 1998; 272
Helmerhorst, Troxler, Oppenheim (2024.05.13.593942v2.16) 2001; 98
Vila, Rizk, Sultan, Jabra-Rizk (2024.05.13.593942v2.7) 2019; 15
Ahmad, Piludu, Oppenheim, Helmerhorst, Hand (2024.05.13.593942v2.12) 2004; 52
Tsuchiya (2024.05.13.593942v2.27) 2021; 9
Salvatori, Puri, Tati, Edgerton (2024.05.13.593942v2.8) 2016; 95
Fidel (2024.05.13.593942v2.21) 2002; 8
da Silva Pedrosa, Sipert, Nogueira (2024.05.13.593942v2.24) 2021; 93
Huang, Pérez, Kato (2024.05.13.593942v2.28) 2021; 27
Edgerton, Koshlukova, Araujo, Patel, Dong, Bruenn (2024.05.13.593942v2.14) 2000; 44
Sultan, Rizk, Vila, Ji, Masri, Jabra-Rizk (2024.05.13.593942v2.35) 2019; 87
Amorim Dos Santos, Normando, Carvalho da Silva, Acevedo, De Luca Canto, Sugaya (2024.05.13.593942v2.5) 2021; 100
Peters, Shirtliff, Jabra-Rizk (2024.05.13.593942v2.10) 2010; 6
Oppenheim, Xu, McMillian, Levitz, Diamond, Offner (2024.05.13.593942v2.11) 1988; 263
Stein, Ramelli, Grazioli, Chung, Singh, Yinda (2024.05.13.593942v2.37) 2022; 612
Sultan, Vila, Hefni, Karlsson, Jabra-Rizk (2024.05.13.593942v2.36) 2019; 63
References_xml – volume: 4
  start-page: 12
  issue: 1
  year: 1994
  end-page: 9
  ident: 2024.05.13.593942v2.13
  article-title: Two coding change mutations in the HIS2(2) allele characterize the salivary histatin 3-2 protein variant
  publication-title: Human Mutation
– volume: 8
  start-page: 69
  issue: Suppl 2
  year: 2002
  end-page: 75
  ident: 2024.05.13.593942v2.21
  article-title: Immunity to Candida
  publication-title: Oral Dis
– volume: 16
  start-page: 250
  year: 2001
  end-page: 2
  ident: 2024.05.13.593942v2.17
  article-title: Antifungal activity of histatin-5 against non-albicans Candida species
  publication-title: Oral Microbiol Immunol
– volume: 92
  start-page: 2556
  issue: 11
  year: 2020
  end-page: 66
  ident: 2024.05.13.593942v2.23
  article-title: Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2
  publication-title: J Med Virol
– volume: 8
  start-page: 1340
  issue: 9
  year: 2020
  ident: 2024.05.13.593942v2.33
  article-title: Recognition of Candida albicans and role of innate type 17 immunity in oral candidiasis
  publication-title: Microorganisms
– volume: 84
  start-page: 2724
  issue: 10
  year: 2016
  end-page: 39
  ident: 2024.05.13.593942v2.19
  article-title: Candida albicans pathogenesis: Fitting within the host-microbe damage response framework
  publication-title: Infect Immun
– volume: 31
  start-page: e2226
  issue: 6
  year: 2021
  ident: 2024.05.13.593942v2.6
  article-title: Covid-19 and oral diseases: Crosstalk, synergy or association?
  publication-title: Rev Med Virol
– volume: 98
  start-page: 14637
  issue: 25
  year: 2001
  end-page: 42
  ident: 2024.05.13.593942v2.16
  article-title: The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species
  publication-title: Proc Nat Acad Sci
– volume: 8
  start-page: e166540
  issue: 24
  year: 2023
  ident: 2024.05.13.593942v2.29
  article-title: Evidence of a Sjögren’s disease-like phenotype following COVID-19 in mice and humans
  publication-title: JCI Insight
– volume: 97
  start-page: 326
  year: 2020
  end-page: 8
  ident: 2024.05.13.593942v2.1
  article-title: Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?
  publication-title: Int J Infect Dis
– volume: 100
  start-page: 154
  year: 2020
  end-page: 7
  ident: 2024.05.13.593942v2.26
  article-title: Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report
  publication-title: Int J Infect Dis
– volume: 100
  start-page: 141
  issue: 2
  year: 2021
  end-page: 54
  ident: 2024.05.13.593942v2.5
  article-title: Oral manifestations in patients with COVID-19: A living systematic review
  publication-title: Dent Res
– volume: 6
  start-page: e1001067
  issue: 10
  year: 2010
  ident: 2024.05.13.593942v2.10
  article-title: Antimicrobial peptides: Primeval molecules or future drugs?
  publication-title: PLoS Pathog
– volume: 11
  start-page: 846
  issue: 13
  year: 2023
  ident: 2024.05.13.593942v2.30
  article-title: Oral candidiasis in adult and pediatric patients with COVID-19
  publication-title: Biomedicines
– volume: 185
  start-page: 607
  issue: 4
  year: 2020
  end-page: 11
  ident: 2024.05.13.593942v2.2
  article-title: Opportunistic fungal Infections in the epidemic area of COVID-19: A cinical and diagnostic perspective from Iran
  publication-title: Mycopathologia
– volume: 6
  start-page: pii
  issue: 1
  year: 2020
  end-page: E15
  ident: 2024.05.13.593942v2.20
  article-title: Oral candidiasis: A disease of opportunity
  publication-title: J Fungi (Basel)
– volume: 63
  start-page: 771
  issue: 8
  year: 2020
  end-page: 8
  ident: 2024.05.13.593942v2.3
  article-title: Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern
  publication-title: Mycoses
– volume: 44
  start-page: 3310
  issue: 12
  year: 2000
  end-page: 6
  ident: 2024.05.13.593942v2.14
  article-title: Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways
  publication-title: Animicrob Agents Chemother
– volume: 95
  start-page: 365
  issue: 4
  year: 2016
  end-page: 71
  ident: 2024.05.13.593942v2.8
  article-title: Innate immunity and saliva in Candida albicans-mediated oral diseases
  publication-title: J Dent Res
– volume: 44
  start-page: 1485
  issue: 6
  year: 2000
  end-page: 93
  ident: 2024.05.13.593942v2.18
  article-title: In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1
  publication-title: Animicrob Agents Chemother
– volume: 93
  start-page: 204
  issue: 1
  year: 2021
  end-page: 5
  ident: 2024.05.13.593942v2.24
  article-title: Are the salivary glands the key players in spreading COVID-19 asymptomatic infection in dental practice?
  publication-title: J Med Virol
– volume: 19
  start-page: 80
  year: 2006
  end-page: 4
  ident: 2024.05.13.593942v2.22
  article-title: Candida-host interactions in HIV disease: Relationships in oropharyngeal candidiasis
  publication-title: Adv Dent Res
– volume: 99
  start-page: 1120
  issue: 10
  year: 2020
  end-page: 1
  ident: 2024.05.13.593942v2.25
  article-title: TMPRSS2 and ACE2 coexpression in SARS-CoV-2 salivary glands infection
  publication-title: J Dent Res
– volume: 9
  start-page: 32
  issue: 3
  year: 2021
  ident: 2024.05.13.593942v2.27
  article-title: Oral symptoms associated with COVID-19 and their pathogenic mechanisms: A literature review
  publication-title: Dent J (Basel
– volume: 5
  start-page: eaau4594
  issue: 43
  year: 2020
  ident: 2024.05.13.593942v2.32
  article-title: Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity
  publication-title: Sci Immunol
– volume: 272
  start-page: 20438
  issue: 32
  year: 1998
  end-page: 47
  ident: 2024.05.13.593942v2.15
  article-title: Candidacidal activity of salivary histatins
  publication-title: J Biol Chem
– volume: 60
  start-page: 881
  issue: 2
  year: 2015
  end-page: 9
  ident: 2024.05.13.593942v2.34
  article-title: Development and in vivo evaluation of a novel histatin-5 bioadhesive hydrogel formulation against oral candidiasis
  publication-title: Antimicrob Agents Chemother
– volume: 612
  start-page: 758
  issue: 7941
  year: 2022
  end-page: 63
  ident: 2024.05.13.593942v2.37
  article-title: SARS-CoV-2 infection and persistence in the human body and brain at autopsy
  publication-title: Nature Biotech
– volume: 14
  start-page: e1006719
  issue: 1
  year: 2018
  ident: 2024.05.13.593942v2.9
  article-title: The oral microbiome: A lesson in co-existence
  publication-title: PLoS Pathog
– volume: 15
  issue: 11
  year: 2019
  ident: 2024.05.13.593942v2.7
  article-title: The power of saliva: Antimicrobial and beyond
  publication-title: Plos Pathog
– volume: 63
  start-page: e00888
  issue: 10
  year: 2019
  end-page: 19
  ident: 2024.05.13.593942v2.36
  article-title: Evaluation of the antifungal and wound healing properties of a novel peptide-based bioadhesive hydrogel formulation
  publication-title: Antimicrob Agents Chemother
– volume: 87
  start-page: e00617
  issue: 12
  year: 2019
  end-page: 19
  ident: 2024.05.13.593942v2.35
  article-title: Digital design of a universal rat intraoral device for therapeutic evaluation of topical formulation against Candida-associated denture stomatitis
  publication-title: Infect Immun
– volume: 52
  start-page: 361
  issue: 3
  year: 2004
  end-page: 70
  ident: 2024.05.13.593942v2.12
  article-title: Immunocytochemical localization of histatins in human salivary glands
  publication-title: J Histochem Cytochem
– volume: 12
  start-page: 831744
  year: 2022
  ident: 2024.05.13.593942v2.38
  article-title: Long-term post-COVID-19 associated oral inflammatory sequelae
  publication-title: Front Cell Infect Microbiol
– volume: 15
  start-page: 465
  issue: 3
  year: 2020
  end-page: 466
  ident: 2024.05.13.593942v2.4
  article-title: Oral candidiasis in non-severe COVID-19 patients: Call for antibiotic stewardship
  publication-title: Oral Surg
– volume: 4
  start-page: 1
  issue: 2
  year: 2013
  end-page: 6
  ident: 2024.05.13.593942v2.31
  article-title: Impaired histatin-5 level and salivary antimicrobial activity against C. albicans in HIV-infected individuals
  publication-title: J AIDS Clin Res
– volume: 263
  start-page: 7472
  issue: 16
  year: 1988
  end-page: 7
  ident: 2024.05.13.593942v2.11
  article-title: Histatins, a novel family of histidine-rich proteins in human parotid secretion
  publication-title: J Biol Chem
– volume: 27
  start-page: 892
  issue: 5
  year: 2021
  end-page: 903
  ident: 2024.05.13.593942v2.28
  article-title: SARS-CoV-2 infection of the oral cavity and saliva
  publication-title: Nat Med
SSID ssj0002961374
Score 1.875494
SecondaryResourceType preprint
Snippet Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species....
SourceID biorxiv
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
SubjectTerms Microbiology
Title SARS-CoV-2 Infection of Salivary Glands Compromises Oral Antifungal Innate Immunity and Predisposes to Oral Candidiasis
URI https://www.ncbi.nlm.nih.gov/pubmed/38798323
https://www.proquest.com/docview/3060750278
https://www.biorxiv.org/content/10.1101/2024.05.13.593942
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA_iEHzz-3tE8LXSfLRNH3VsboJzbCp7K0mTwkDa0c2P_ffetXX4oOBbKbmGXu4uv-S-CLkKnfUt4AxPaV94KCGeYk57odaw3cVWMIf5zg_DsP8s76fB9EerLwyrNLOi_Jy9V358DNgG61srt8_wrC6x1CYT10EsYgnWtwUixbFrQ296vb5e4THsU5Fs_Ji_UgLibWb6G11Wu0xvh7RGeu7KXbLh8j2yVbeJXO2Tj8nNeOJ1iheP00ETPJXTIqMTjY6cckXvqoxdispdFrBybkEfS_1KbzAUCNQZHgd5DrCSDqp8kOWKAgEdlZiVOy9w_LKoSTqY5wJCs5gtDshzr_vU6XtNwwTPVIdKK8IwMkyaIDR-CtgqsxZ7HSobp4EwVjHfMh5lmlurU2V9Bito0sgA7pCYlHtINvMid8eEhgHWPuOpNCqTOpQaLAFnlmkVpTwL4hNy2TAvmddlMRJkcOIHCRNJzWAY883WBH4dPRE6d8XbIoFzCkIVHqkTclTze_0ZoaIYzIw4_ccMZ2Qb32HoFmPnZHNZvrkLAAlL0yat2-5wNG5XYvEFDaK25w
linkProvider Cold Spring Harbor Laboratory Press
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8QwEA4eiL55u54RfO3SHG3TR1lcd71xVfatJE0KC9Iu7Xrsv3emrT4p-FZo0tDJZObLzDcJIWehs74FnOEp7QsPNcRTzGkv1BrcXWwFc1jvfHsXDp7l1TgYtwG3qqVVmklRfk7e6zw-ErbB-jaL22e4V5d41CYT3SAWseRdDFMvkmXQK4aUrv64-xNj4TE4q0i2ycxfuwPsbYf7G2LWrqa_TpYf9NSVG2TB5Ztkpbkrcr5FPkbnjyOvV7x4nA5bBlVOi4yONGZzyjm9rMt2Ka7wsoDpcxW9L_UrPUc-EKxpeBzmOWBLOqyLQmZzCh3oQ4mludMC28-KpksPi11Ac6pJtU2e-xdPvYHX3prgmXpnaUUYRoZJE4TGTwFgZdbihYfKxmkgjFXMt4xHmebW6lRZn8E0mjQyAD4kVubukKW8yN0eoWGAB6DxVBqVSR1KDeaAM8u0ilKeBXGHnLbCS6bN2RgJCjjxg4SJpBEwtPkWawK_jukInbvirUpgs4J4hUeqQ3Ybef98RqgoBlsj9v8xwglZHTzd3iQ3w7vrA7KG75HLxdghWZqVb-4IUMPMHNeq8QXANbok
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwELVYBOLGTlmNxDVVvCRxjqhQKGtFAfUW2bEjVUJJlZalf89MEhAHkLhF8qaMZ-xnzzwPISehs74FnOEp7QsPNcRTzGkv1Bq2u9gK5pDvfHsXXj7Jq2Ew_MGFwbBKMyrKj9Fb5cfHgG1YfWvj9hme1SU-tclEO4hFLHkbr6nbY5vNk0XQLYaa3R22v-9ZeAwbViQbh-avXQD0bYb8G2ZW2013lSz29diVa2TO5etkqc4XOdsg74PTh4HXKZ49TntNFFVOi4wONHp0yhm9qKi7FK28LGAK3YTel_qFnmJMENg1fPbyHPAl7VXEkOmMQgPaL5GeOy6w_rSom3SQ8ALaMxlNNslT9_yxc-k1mRM8U50urQjDyDBpgtD4KYCszFpMeqhsnAbCWMV8y3iUaW6tTpX1GUylSSMDAEQiO3eLLORF7nYIDQN8BI2n0qhM6lBqWBI4s0yrKOVZELfIcSO8ZFy_j5GggBM_SJhIagFDnS-xJvDr6JLQuSteJwkcWBCz8Ei1yHYt7-9uhIpiWG_E7j9GOCLL_bNuctO7u94jK1iM4VyM7ZOFafnqDgA4TM1hpRmflcK7NQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SARS-CoV-2+Infection+of+Salivary+Glands+Compromises+Oral+Antifungal+Innate+Immunity+and+Predisposes+to+Oral+Candidiasis&rft.jtitle=bioRxiv&rft.au=Alfaifi%2C+Areej+A&rft.au=Wang%2C+Tristan+W&rft.au=Perez%2C+Paola&rft.au=Sultan%2C+Ahmed+S&rft.date=2024-06-11&rft.issn=2692-8205&rft.eissn=2692-8205&rft_id=info:doi/10.1101%2F2024.05.13.593942&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2692-8205&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2692-8205&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2692-8205&client=summon